Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in ...

BioArctic signed the first deal for its “brain transporter” with Bristol Myers Squibb late last year. The deal is worth up to $1.4bn and allows the US drugmaker to start trials using the technology to ...

Financial writer advises caution on Jyong Biotech Ltd. IPO due to high debt, legal issues, and FDA challenges. Click for my ...

A federal judge will soon decide whether to dismiss a lawsuit against UnitedHealth Group alleging that the company and its ...

Biotechnology is transforming the beauty industry, yet remains misunderstood – here the Covalo Data & Insights Team argues ...

A new partnership between APW High School and local innovator BioSpherix is focusing on real world knowledge and exposure.

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...

Agoura Hills-based biotech firm Acelyrin Inc. agreed to merge with San Francisco-based Alumis Inc. in a deal valued at $320 ...

China issued guidelines on Friday to promote biotech cultivation, focusing on gene-editing tools and developing new wheat, ...

The aggregate gross proceeds to the Company from the offering are expected to be approximately $1.05 million, before ...

The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was ...

Viracta, a California biotech oncology firm, is laying off every remaining employee and shutting down after its cash stores ...